{
    "nctId": "NCT03456661",
    "briefTitle": "Comparison Between Levobupivacaine and Levobupivacaine With Dexmedetomidine in Ultrasound Guided Pectoral Nerve Block",
    "officialTitle": "Comparison Between Levobupivacaine 0.25% and Levobupivacaine With Dexmedetomidine in Ultrasound Guided Modified Pectoral Nerve Block, a Double Blind Randomised Controlled Trial.",
    "overallStatus": "TERMINATED",
    "conditions": "Breast Cancer, Mastectomy, Modified Radical",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE4",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 40,
    "primaryOutcomeMeasure": "Total postoperative opioid (morphine) consumption",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* women,\n* 18years and older\n* American Society of Anesthesiologists 1, 2,3,\n* planned for radical mastectomy.\n\nExclusion Criteria:\n\n* Neurological problems (central and peripheral)\n* Bilateral mastectomy\n* Body Mass Index \\> 33,\n* Absolute contra-indication for ketorolac.\n* Allergy/over-sensitiveness to levobupivacaine or local anesthetics of the same class\n* Allergy/over-sensitiveness to dexmedetomidine or other alpha2 agonists (clonidine)\n* Anatomic variations of the breast, pectoral region or axilla, noticed at clinical examination, including a pacemaker, Implantable Cardioverter Defibrillator, Port-a-Cath or other implantable device on the side that needs surgery.\n* Participation in an other clinical trial within a period of four weeks before the beginning of this trial.\n* Coagulopathy\n* Infection or abcess in the region where the Block will be placed.\n* Pregnancy",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}